Lower levels of sodium intake and reduced cardiovascular risk
- PMID: 24415713
- PMCID: PMC4181831
- DOI: 10.1161/CIRCULATIONAHA.113.006032
Lower levels of sodium intake and reduced cardiovascular risk
Abstract
Background: Recent studies have raised the possibility of adverse effects of low sodium, particularly <2300 mg/d, on cardiovascular disease; however, these paradoxical findings might have resulted from suboptimal measurement of sodium and potential biases related to indication or reverse causation.
Methods and results: Phases 1 and 2 of the Trials of Hypertension Prevention (TOHP) collected multiple 24-hour urine specimens among prehypertensive individuals. During extended post-trial surveillance, 193 cardiovascular events or cardiovascular disease deaths occurred among 2275 participants not in a sodium reduction intervention with 10 (TOHP II) or 15 (TOHP I) years of post-trial follow-up. Median sodium excretion was 3630 mg/d, with 1.4% of the participants having intake <1500 mg/d and 10% <2300 mg/d, consistent with national levels. Compared with those with sodium excretion of 3600 to <4800 mg/d, risk for those with sodium <2300 mg/d was 32% lower after multivariable adjustment (hazard ratio, 0.68; 95% confidence interval, 0.34-1.37; P for trend=0.13). There was a linear 17% increase in risk per 1000 mg/d increase in sodium (P=0.05). Spline curves supported a linear association of sodium with cardiovascular events, which continued to decrease from 3600 to 2300 and 1500 mg/d, although the data were sparse at the lowest levels. Controlling for creatinine levels had little effect on these results.
Conclusions: Results from the TOHP studies, which overcome the major methodological challenges of prior studies, are consistent with overall health benefits of reducing sodium intake to the 1500 to 2300 mg/d range in the majority of the population, in agreement with current dietary guidelines.
Keywords: cardiovascular diseases; diet; nutrition; primary prevention; sodium chloride, dietary.
Figures
Comment in
-
Lower levels of sodium intake and reduced cardiovascular risk: the challenge to achieve lower sodium recommendations.Circulation. 2014 Mar 4;129(9):956-7. doi: 10.1161/CIRCULATIONAHA.114.007964. Epub 2014 Jan 10. Circulation. 2014. PMID: 24415712 No abstract available.
-
Letter from Cohen and Alderman regarding article, "lower levels of sodium intake and reduced cardiovascular risk".Circulation. 2014 Dec 2;130(23):e268. doi: 10.1161/CIRCULATIONAHA.114.009369. Circulation. 2014. PMID: 25446064 No abstract available.
-
Response to letter regarding article, "lower levels of sodium intake and reduced cardiovascular risk".Circulation. 2014 Dec 2;130(23):e269. doi: 10.1161/CIRCULATIONAHA.114.013280. Circulation. 2014. PMID: 25446065 No abstract available.
References
-
- IOM (Institute of Medicine) Sodium intake in populations: Assessment of evidence. Washington, DC: The National Academies Press; 2013.
-
- Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett GK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD on behalf of the American Heart Association Strategic Planning Task Force and Statistics Committe. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond. Circulation. 2010;121:586–613. - PubMed
-
- Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC, Jr, Vafiadis DK, Van Horn LV. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation. 2011;123:1138–1143. - PubMed
-
- WHO. Guideline: Sodium intake for adults and children. Geneva: World Health Organization (WHO); 2012. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL37849/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- HL37907/HL/NHLBI NIH HHS/United States
- HL37899/HL/NHLBI NIH HHS/United States
- HL37852/HL/NHLBI NIH HHS/United States
- HL37872/HL/NHLBI NIH HHS/United States
- HL37884/HL/NHLBI NIH HHS/United States
- HL37924/HL/NHLBI NIH HHS/United States
- HL37853/HL/NHLBI NIH HHS/United States
- HL37915/HL/NHLBI NIH HHS/United States
- HL37854/HL/NHLBI NIH HHS/United States
- HL37904/HL/NHLBI NIH HHS/United States
- HL37906/HL/NHLBI NIH HHS/United States
- R01 HL057915/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical